DOI: 10.1055/s-00023610

Drug Research

References

Ambery P, Parker VE, Stumvoll M. et al.
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: A randomised, controlled, double-blind, ascending dose and phase 2a study.

Lancet 2018;
391: 2607-2618

Download Bibliographical Data

Access:
Access:
Access: